Yes, you should repeat glucose testing now at 5 months
For a patient with prediabetes diagnosed 5 months ago, repeat testing is recommended now, particularly if they have additional risk factors or if their initial values were near the margins of diagnostic thresholds.
Rationale for Repeat Testing at 5 Months
The most recent ADA guidelines 1 recommend that patients with test results near the margins of diagnostic thresholds should be followed closely and have testing repeated in 3-6 months. At 5 months, your patient falls within this recommended window.
Key Considerations:
When to Repeat Testing:
- If initial prediabetes values were borderline (e.g., A1C 5.7-5.9%, FPG 100-110 mg/dL), repeat testing at 3-6 months is appropriate 1
- If values were higher in the prediabetes range (e.g., A1C 6.0-6.4%, FPG 115-125 mg/dL), more frequent monitoring is warranted 2
- The presence of additional risk factors (obesity, family history, hypertension, dyslipidemia) increases urgency for repeat testing 3
What Tests to Order:
The 2019 ADA guidelines 1 recommend using the same test that was initially abnormal for confirmation. However, you have three appropriate options:
- A1C (most reproducible, least variability) 4, 5
- Fasting plasma glucose (FPG) (more variability than A1C)
- 2-hour 75-g OGTT (most variability, but may detect diabetes missed by other tests) 6
Critical Point: If you use both FPG and A1C and both meet prediabetes criteria, this confirms dysglycemia with 98.6% certainty on repeat testing 6. This dual approach is particularly valuable for risk stratification.
Why This Matters for Outcomes
Progression Risk:
- Individuals with prediabetes progress to diabetes at 5-10% annually 7
- Those who repeatedly meet prediabetes criteria in both FPG and A1C have dramatically elevated risk: odds ratios of 11.5,20.0, and 63.5 for one, two, and three consecutive positive tests respectively 2
- Approximately 10% of US adults with prediabetes develop diabetes each year 7
Cardiovascular Risk:
- Prediabetes itself is associated with increased mortality (excess absolute risk 7.36 per 10,000 person-years) and cardiovascular events (8.75 per 10,000 person-years) during 6.6 years of follow-up 7
- Early identification allows for cardiovascular risk factor management 3
Intervention Window:
- Intensive lifestyle modification reduces diabetes incidence by 6.2 cases per 100 person-years over 3 years 7
- Metformin reduces risk by 3.2 cases per 100 person-years 7
- The duration of glycemic burden is a strong predictor of adverse outcomes 8
Common Pitfalls to Avoid
Test Variability Issues:
- All glucose tests have preanalytic and analytic variability 1
- For FPG and 2-hour PG, samples must be spun and separated immediately after collection to avoid falsely low results 1, 9
- A1C has the least variability, making it the most reliable for monitoring 4, 5
- Be aware that measurement variation can cause apparent "progression" or "regression" 10
Hemoglobin Variants:
- A1C may be unreliable in patients with hemoglobin variants, sickle cell trait, recent blood loss/transfusion, iron deficiency anemia, or certain medications 1, 9
- If marked discrepancies exist between A1C and glucose values, consider using glucose-based testing only 1
Risk of Underdiagnosis:
- Up to 62.6% of diabetes cases in high-risk prediabetic individuals are detected only by 2-hour OGTT 6
- If initial testing used only FPG or A1C, consider adding OGTT if clinical suspicion is high 6
Ongoing Monitoring Strategy
After This 5-Month Test:
- If still prediabetic: repeat testing annually 3, 11
- If progression to diabetes: initiate appropriate diabetes management
- If regression to normal: continue lifestyle interventions and retest at 3-year intervals 3
- If values remain stable in mid-prediabetes range without risk factors: annual monitoring is sufficient 3
Standard screening intervals for those without prediabetes are every 3 years 3, 12, 3, but your patient has already crossed into the prediabetes category, necessitating more frequent surveillance.